Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-26T20:05:15.507Z Has data issue: false hasContentIssue false
  • English
  • Français

Pemoline and neuroleptic-induced side effects

Published online by Cambridge University Press:  13 June 2014

Philip L Huckle  and
Roger Thomas
Philip L Huckle
Affiliation:
Glanrhyd Hospital, Bridgend, Mid Glamorgan CF31 4LN, Wales.
Roger Thomas
Affiliation:
Whitchurch Hospital, Cardiff. Wales.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 8 , Issue 2 , September 1991 , pp. 174
Copyright
Copyright © Cambridge University Press 1991

References

l.Scheel-Kruger, J. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur Journal Pharmacol 1971; 14: 47–59.CrossRefGoogle Scholar
2.Chiarello, RJ, Cole, JA. The use of psychostimulants in general psychiatry. Arch Gen Psychiatry 1987; 44: 286–95.CrossRefGoogle ScholarPubMed
3.Kiloh, CG, Neilson, M, Andrews, G. Response of depressed patients to methamphetamine. Br J Psychiatry 1964; 125: 496–99.CrossRefGoogle Scholar
4.Casey, JF, Hollister, LE, Kless, CJ. Combined drug therapy of chronic schizophrenia. Am J Psychiatry 1961; 117: 997–99.CrossRefGoogle Scholar
5.Lierberman, JA, Kane, JM, Alvin, J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmocology 1987; 91: 415–33.CrossRefGoogle Scholar